Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 Infection
Open Access
- 1 November 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (46), 35488-35496
- https://doi.org/10.1074/jbc.m110.163659
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical TrialsPLOS ONE, 2010
- Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)Journal of Biological Chemistry, 2010
- Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal MucusJournal of Virology, 2009
- Glycerol monolaurate prevents mucosal SIV transmissionNature, 2009
- Mycoplasma genitalium -Encoded MG309 Activates NF-κB via Toll-Like Receptors 2 and 6 To Elicit Proinflammatory Cytokine Secretion from Human Genital Epithelial CellsInfection and Immunity, 2009
- The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus InfectionJournal of Virology, 2009
- Vaginal microbicides and the prevention of HIV transmissionThe Lancet Infectious Diseases, 2008
- Assay To Screen for Molecules That Associate with Alzheimer's Related β-Amyloid FibrilsAnalytical Chemistry, 2008
- Seminal Plasma Reduces the Effectiveness of Topical Polyanionic MicrobicidesThe Journal of Infectious Diseases, 2007
- A Comprehensive Murine Model to Evaluate Topical Vaginal Microbicides: Mucosal Inflammation and Susceptibility to Genital Herpes as Surrogate Markers of SafetyThe Journal of Infectious Diseases, 2007